Increased cholinergic contractions of jejunal smooth muscle caused by a high cholesterol diet are prevented by the 5-HT4 agonist - Tegaserod

BMC Gastroenterology

Volumn 6, Issue , 2006, Pages

  Mathison, Ronald ^a   Shaffer, Eldon ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBACHOL; HEXAMETHONIUM; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NICOTINIC RECEPTOR BLOCKING AGENT; SCOPOLAMINE; SEROTONIN 4 AGONIST; SEROTONIN 4 RECEPTOR; TEGASEROD; TETRODOTOXIN; CHOLINERGIC RECEPTOR STIMULATING AGENT; GANGLION BLOCKING AGENT; INDOLE DERIVATIVE; SEROTONIN AGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL DIET; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; IN VITRO STUDY; INTESTINE INNERVATION; INTESTINE MUSCLE; JEJUNUM; LIPID ANALYSIS; LOW FAT DIET; MUSCLE ACTION POTENTIAL; NONHUMAN; RECEPTOR BLOCKING; SMOOTH MUSCLE CONTRACTION; SQUIRREL; TISSUE SECTION; ACTION POTENTIAL; ANIMAL; CHOLESTEROL INTAKE; DISEASE MODEL; INNERVATION; MUSCLE CONTRACTION; PHYSIOLOGY; SCIURIDAE; SMOOTH MUSCLE;

ACTION POTENTIALS; ANIMALS; CARBACHOL; CHOLESTEROL, DIETARY; CHOLINERGIC AGONISTS; DISEASE MODELS, ANIMAL; ENTERIC NERVOUS SYSTEM; GANGLIONIC BLOCKERS; HEXAMETHONIUM; INDOLES; JEJUNUM; MUSCLE CONTRACTION; MUSCLE, SMOOTH; SCIURIDAE; SEROTONIN RECEPTOR AGONISTS;

EID: 33645642530     PISSN: 1471230X     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-6-8     Document Type: Article

References (50)

1. Zapata R, Severin C, Manriquez M, Valdivieso V: Gallbladder motility and lithogenesis in obese patients during diet-induced weight loss. Dig Dis Sci 2000, 45:421-428.
2. Portincasa P, Di Ciaula A, vanBerge-Henegouwen GP: Smooth muscle function and dysfunction in gallbladder disease. Curr Gastroenterol Rep 2004, 6:151-162.
3. Azzaroli F, Mazzella G, Mazzeo C, Simoni P, Festi D, Colecchia A, Montagnani M, Martino C, Villanova N, Roda A, Roda E: Sluggish small bowel motility is involved in determining increased biliary deoxycholic acid in cholesterol gallstone patients. Am J Gastroenterol 1999, 94:2453-2459.
4. Lewis SJ, Heaton KW: The metabolic consequences of slow colonic transit. Am J Gastroenterol 1999, 94:2010-2016.
5. Hardison WG, Tomaszewski N, Grundy SM: Effect of acute alterations in small bowel transit time upon the biliary excretion rate of bile acids. Gastroenterology 1979, 76:568-574.
6. Marcus SN, Heaton KW: Intestinal transit, deoxycholic acid and the cholesterol saturation of bile - three inter-related factors. Gut 1986, 27:550-558.
7. Brenneman DE, Connor WE, Forker EL, DenBesten L: The formation of abnormal bile and cholesterol gallstones from dietary cholesterol in the prairie dog. J Clin Invest 1972, 51:1495-503.
8. Fridhandler TM, Davison JS, Shaffer EA: Defective gallbladder contractility in the ground squirrel and prairie dog during the early stages of cholesterol gallstone formation. Gastroenterology 1983, 85:830-836.
9. Xu QW, Scott RB, Tan DT, Shaffer EA: Slow intestinal transit: A motor disorder contributing to cholesterol gallstone formation in the ground squirrel. Hepatology 1996, 23:1664-1672.
10. Xu QW, Scott RB, Tan DT, Shaffer EA: Effect of the prokinetic agent, erythromycin, in the Richardson ground squirrel model of cholesterol gallstone disease. Hepatology 1998, 28:613-619.
11. Xu QW, Shaffer EA: Cisapride improves gallbladder contractility and bile lipid composition in an animal model of gallstone disease. Gastroenterology 1993, 105:1184-1191.
12. Kaumann AJ: Do human atrial 5-HT4 receptors mediate arrhythmias? Trends Pharmacol Sci 1994, 15:451-455.
13. Nguyen A, Camilleri M, Kost LJ, Metzger A, Sarr MG, Hanson RB, Fett SL, Zinsmeister AR: SDZ HTF 919 stimulates canine colonic motility and transit in vivo. J Pharmacol Exp Ther 1997, 280:1270-1276.
14. Longstreth GF, Yao JF: Irritable bowel syndrome and surgery: A multivariable analysis. Gastroenterology 2004, 126:1665-1673.
15. Fisher RS, Thistle J, Lembo A, Novick J, O'Kane P, Chey WD, Beglinger C, Rueegg P, Shi V, Dogra A, Luo D, Earnest DL: Tegaserod does not alter fasting or meal-induced biliary tract motility. Am J Gastroenterol 2004, 99:1342-1349.
16. Gershon MD: Serotonin and its implication for the management of irritable bowel syndrome. Rev Gastroenterol Disord 2003, 3(Suppl 2):S25-34.
17. Yamamoto I, Kuwahara A, Fujimura M, Kadowaki M, Fujimiya M: Involvement of 5-HT3 and 5-HT4 receptors in the motor activity of isolated vascularly perfused rat duodenum. Neurogastroenterol Motil 1999, 11:457-465.
18. Katschinski M, Schirra J, Begliner C, Langbein S, Wank U, D'Amato M, Arnold R: Intestinal phase of human antro-pyloro-duodenal motility: Cholinergic and CCK-mediated regulation. Eur J Clin Invest 1996, 26:574-583.
19. Schoenfeld P: Review article: The safety profile of tegaserod. Aliment Pharmacol Ther 2004, 20(Suppl 7):25-30.
20. Ono K, Nakayoshi A, Suzuki K, Scott GW, Clanachan AS: Gallbladder contractility and gallstone formation in the Richardson Ground Squirrel. Gostroenterol Jpn 1990, 25:93-103.
21. Behar J, Lee KY, Thompson WR, Biancani P: Gallbladder contraction in patients with pigment and cholesterol stones. Gastroenterology 1989, 97:1479-1484.
22. Mansour A, Dawoud I, Gad-El-Hak N: The potential site of disordered gallbladder contractility during the early stage of cholesterol gallstone formation. Hepatogastroenterology 1998, 45:1404-1409.
23. Xu QW, Freedman SM, Shaffer EA: Inhibitory effect of bile salts on gallbladder smooth muscle contractility in the guinea pig in vitro. Gastroenterology 1997, 112:1699-1706.
24. Stolk MF, Van de Heijning BJ, Van Erpecum KJ, Verheem A, Akkermans LM, Van Berge-Henegouwen GP: Effect of bile salts on in vitro gallbladder motility: Preliminary study. Ital J Gastroenterol 1996, 28:105-111.
25. Booker ML, LaMorte WW, Beer ER, Hopkins SR: Effects of dietary cholesterol and triglycerides on lipid concentrations in liver, plasma, and bile. Lipids 1997, 32:163-172.
26. Raufman JP, Chen Y, Zimniak P, Cheng K: Deoxycholic acid conjugates are muscarinic cholinergic receptor antagonists. Pharmacology 2002, 65:215-221.
27. Lewis MC, Root C: In vivo transport kinetics and distribution of taurocholate by rat ileum and jejunum. Am J Physiol 1990, 259:G233-238.
28. Burger K, Gimpl G, Fahrenholz F: Regulation of receptor function by cholesterol. Cell Mol Life Sci 2000, 57:1577-1592.
29. Puglielli L, Tanzi RE, Kovacs DM: Alzheimer's disease: The cholesterol connection. Nat Neurosci 2003, 6:345-351.
30. Robertson AK, Zhou X, Strandvik B, Hansson GK: Severe hypercholesterolaemia leads to strong Th2 responses to an exogenous antigen. Scand J Immunol 2004, 59:285-293.
31. Stokes KY, Cooper D, Tailor A, Granger DN: Hypercholesterolemia promotes inflammation and microvascular dysfunction: Role of nitric oxide and superoxide. Free Radic Biol Med 2002, 33:1026-1036.
32. Portincasa P, Di Ciaula A, Vendemiale G, Palmieri V, Moschetta A, Vanberge-Henegouwen GP, Palasciano G: Gallbladder motility and cholesterol crystallization in bile from patients with pigment and cholesterol gallstones. Eur J Clin Invest 2000, 30:317-24.
33. Nagorna-Stasiak B: Effect of cholesterol on intestinal motility in rabbits in chronic experiments. Pol Arch Weter 1987, 24:445-455. [Polish]
34. Szilvassy Z, Sari R, Nemeth J, Nagy I, Csati S, Lonovics J: Improvement of nitrergic relaxation by farnesol of the sphincter of Oddi from hypercholesterolaemic rabbits. Eur J Pharmacol 1998, 353:75-78.
35. Herman JR, Bass P: Altered carbachol-induced contractile responses of rat jejunal smooth muscle following local myenteric plexus ablation. Dig Dis Sci 1990, 35:1146-1152.
36. De Man JG, Moreels TG, De Winter BY, Bogers JJ, Van Marck EA, Herman AG, Pelckmans PA: Disturbance of the prejunctional modulation of cholinergic neurotransmission during chronic granulomatous inflammation of the mouse ileum. Br J Pharmacol 2001, 133:695-707.
37. Galligan JJ: Nerve terminal nicotinic cholinergic receptors on excitatory motoneurons in the myenteric plexus of guinea pig intestine. J Pharmacol Exp Ther 1999, 291:92-98.
38. Galligan JJ, Pan H, Messori E: Signalling mechanism coupled to 5-hydroxytryptamine4 receptor-mediated facilitation of fast synaptic transmission in the guinea-pig ileum myenteric plexus. Neurogastroenterol Motil 2003, 15:523-529.
39. Iversen HH, Wiklund NP, Olgart C, Gustafsson LE: Nerve stimulation-induced nitric oxide release as a consequence of muscarinic MI receptor activation. Eur J Pharmacol 1997, 331:213-219.
40. Kilbinger H, Nafziger M: Two types of neuronal muscarine receptors modulating acetylcholine release from guinea-pig myenteric plexus. Naunyn Schmiedebergs Arch Pharmacol 1985, 328:304-309.
41. Kurjak M, Sattler D, Schusdziarra V, Allescher HD: Characterization of prejunctional and postjunctional muscarinic receptors of the ascending reflex contraction in rat ileum. J Pharmacol Exp Ther 1999, 290:893-900.
42. Briejer MR, Bosmans JP, Van Daele P, Jurzak M, Heylen L, Leysen JE, Prins NH, Schuurkes JA: The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound. Eur J Pharmacol 2001, 423:71-83.
43. Prins NH, Akkermans LM, Lefebvre RA, Schuurkes JA: 5-HT(4) receptors on cholinergic nerves involved in contractility of canine and human large intestine longitudinal muscle. Br J Pharmacol 2000, 131:927-932.
44. Graf S, Sarna SK: 5-HT-induced jejunal motor activity: Enteric locus of action and receptor subtypes. Am J Physiol 1996, 270:G992-1000.
45. Grider JR: Neurotransmitters mediating the intestinal peristaltic reflex in the mouse. J Pharmacol Exp Ther 2003, 307:460-467.
46. Foxx-Orenstein AE, Kuemmerle JF, Grider JR: Distinct 5-HT receptors mediate the peristaltic reflex induced by mucosal stimuli in human and guinea pig intestine. Gastroenterology 1996, 111:1281-1290.
47. 4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine. Gastroenterology 1998, 115:370-380.
48. Linnik MD, Butler BT, Elsea SH, Ahmed NK: Analysis of neurogenic contractions induced by ML-1035 and other benzamides in the guinea-pig non-stimulated isolated ileum. J Pharm Pharmacol 1994, 46:491-496.
49. Schikowski A, Thewissen M, Mathis C, Ross HG, Enck P: Serotonin type-4 receptors modulate the sensitivity of intramural mechanoreceptive afferents of the cat rectum. Neurogastroenterol Motil 2002, 14:221-227.
50. Sanger GJ: Three different ways in which 5-hydroxytryptamine can affect cholinergic activity in guinea-pig isolated ileum. J Pharm Pharmacol 1985, 37:584-586.